0001349929-16-000064.txt : 20160316 0001349929-16-000064.hdr.sgml : 20160316 20160316165223 ACCESSION NUMBER: 0001349929-16-000064 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160315 FILED AS OF DATE: 20160316 DATE AS OF CHANGE: 20160316 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CANCER GENETICS, INC CENTRAL INDEX KEY: 0001349929 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 043462475 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 ROUTE 17 NORTH STREET 2: 2ND FLOOR CITY: RUTHERFORD STATE: NJ ZIP: 07070 BUSINESS PHONE: 201.528.9200 MAIL ADDRESS: STREET 1: 201 ROUTE 17 NORTH STREET 2: 2ND FLOOR CITY: RUTHERFORD STATE: NJ ZIP: 07070 FORMER COMPANY: FORMER CONFORMED NAME: CANCER GENETICS INC DATE OF NAME CHANGE: 20060117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAPPAJOHN JOHN CENTRAL INDEX KEY: 0000897464 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35817 FILM NUMBER: 161510293 MAIL ADDRESS: STREET 1: 1660 WALT WHITMAN ROAD STREET 2: SUITE 105 CITY: MELVILLE STATE: NY ZIP: 11747 4 1 wf-form4_145816153240961.xml FORM 4 X0306 4 2016-03-15 0 0001349929 CANCER GENETICS, INC CGIX 0000897464 PAPPAJOHN JOHN 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 1 0 1 0 Common Stock, par value $0.0001 per share 2016-03-15 4 P 0 89421 2.5178 A 1711210 D Common Stock, par value $0.0001 per share 2016-03-16 4 P 0 10579 2.6216 A 1721789 D 1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.23 to $2.60, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. 2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.53 to $2.65, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. /s/ John Pappajohn by Edward J Sitar as Attorney-in-fact 2016-03-16